IP Library Patent Application 18415753
Patent Application
App. No. 18/415,753

ELECTROCARDIOGRAM MORPHOLOGY EVALUATION MANAGEMENT IN IMPLANTABLE DEVICE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/415,753
Abstract

The present invention discloses means and methods for performing evaluation of an electrocardiogram (ECG) morphology in an implantable device, optionally the implantable device has a single ECG sensing lead.

Claims (50)

1 . A method of performing morphology evaluation processes in an implantable device, the method comprising:

a. providing instructions to said implantable device for performing a morphology evaluation process at a determined timing according to predetermined parameters;

b. activating said morphology evaluation process for a predetermined period of time following sensing said predetermined parameters.

2 . The method according to claim 1 , wherein said predetermined parameters are one or more of a scheduled stimulation event and a tachycardia event.

3 . The method according to claim 2 , wherein said scheduled stimulation are one or more of Cardiac contractility modulation and CRT.

4 . The method according to claim 2 , wherein when said predetermined parameters is a scheduled stimulation event, then said predetermined period of time is at least one selected form the group consisting of:

a. up to 500 mS; and

b. up to 50 mS.

5 . The method according to claim 2 , wherein said tachycardia event is defined when a heart rate is above 100 beats per minute (BPM).

6 . The method according to claim 2 , wherein when said predetermined parameters is a tachycardia event, then said predetermined period of time is as long as said tachycardia event is sensed.

7 . The method according to claim 2 , wherein when said predetermined parameters is a tachycardia event, then said predetermined period of time is of equal or greater than 1000 mS.

8 . The method according to claim 1 , wherein said predetermined parameters are one or more of:

a. a detected atrial-ventricle (A-V) timing delay above a predetermined threshold;

b. a detected right ventricle-left ventricle (V-V) timing delay above a predetermined threshold; and

c. a detected P-P delay that is different from an R-R delay.

9 . The method according to claim 8 , wherein when said predetermined parameters is one or more of:

a. a detected atrial-ventricle (A-V) timing delay above a predetermined threshold;

b. a detected right ventricle-left ventricle (V-V) timing delay above a predetermined threshold; and

c. a detected P-P delay that is different from an R-R delay;

then said predetermined period of time is of up to 500 mS or up to 100 mS.

10 . The method according to claim 8 , wherein:

a. said predetermined threshold of said atrial-ventricle (A-V) timing delay is a sensed value above 180 mS;

b. said predetermined threshold of said atrial-ventricle (A-V) timing delay is a change of more than 10 mS from baseline measured A-V delay;

c. said predetermined threshold of said right ventricle-left ventricle (V-V) timing delay is a sensed value above 10 mS;

d. said predetermined threshold of said right ventricle-left ventricle (V-V) timing delay is a change of more than 1 mS from baseline measured V-V delay.

11 . A system for performing morphology evaluation processes in an implantable device comprising an implantable controller, said controller configured to carry out the method of:

a. performing a morphology evaluation process at a determined timing according to predetermined parameters;

b. activating said morphology evaluation process for a predetermined period of time following sensing said predetermined parameters.

12 . The system according to claim 11 , wherein said predetermined parameters are one or more of a scheduled stimulation event and a tachycardia event.

13 . The system according to claim 12 , wherein said scheduled stimulation are one or more of Cardiac contractility modulation and CRT.

14 . The system according to claim 12 , wherein when said predetermined parameters is a scheduled stimulation event, then said predetermined period of time is at least one selected form the group consisting of:

a. up to 500 mS; and

b. up to 50 mS.

15 . The system according to claim 12 , wherein said tachycardia event is defined when a heart rate is above 100 beats per minute (BPM).

16 . The system according to claim 12 , wherein when said predetermined parameters is a tachycardia event, then said predetermined period of time is as long as said tachycardia event is sensed.

17 . The system according to claim 12 , wherein when said predetermined parameters is a tachycardia event, then said predetermined period of time is of equal or greater than 1000 mS.

18 . The system according to claim 11 , wherein said predetermined parameters are one or more of:

a. a detected atrial-ventricle (A-V) timing delay above a predetermined threshold;

b. a detected right ventricle-left ventricle (V-V) timing delay above a predetermined threshold; and

c. a detected P-P delay that is different from an R-R delay.

19 . The system according to claim 18 , wherein when said predetermined parameters is one or more of:

a. a detected atrial-ventricle (A-V) timing delay above a predetermined threshold;

b. a detected right ventricle-left ventricle (V-V) timing delay above a predetermined threshold; and

c. a detected P-P delay that is different from an R-R delay;

then said predetermined period of time is of up to 500 mS or up to 100 mS.

20 . The system according to claim 18 , wherein:

a. said predetermined threshold of said atrial-ventricle (A-V) timing delay is a sensed value above 180 mS;

b. said predetermined threshold of said atrial-ventricle (A-V) timing delay is a change of more than 10 mS from baseline measured A-V delay;

c. said predetermined threshold of said right ventricle-left ventricle (V-V) timing delay is a sensed value above 10 mS;

d. said predetermined threshold of said right ventricle-left ventricle (V-V) timing delay is a change of more than 1 mS from baseline measured V-V delay.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2024
From: PRUTCHI, DAVID; BEN DAVID, TAMIR
To: IMPULSE DYNAMICS NV
Reel/Frame 066793/0522 →